跳至主要内容
临床试验/CTRI/2025/04/084669
CTRI/2025/04/084669尚未招募Phase 3 4

Pharmacotherapeutic evaluation of Paribhadra Patra (Erythrina variegata Linn.) and Amlaki phala (Emblica officinalis Gaertn.) in the management of Amlapitta (Hyperacidity) - An exploratory study

PGIA DSRRAU Jodhpur1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年2月6日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Changes in the objective parameters

研究概览

简要总结

My study titled "Pharmacotherapeutical Evaluation of Paribhadra Patra and Amalaki Phala in the Management of Amlapitta (Hyperacidity)" focuses on assessing the effectiveness of two traditional Ayurvedic remedies—Paribhadra Patra (leaves of Erythrina variegata) and Amalaki Phala (fruit of the Indian gooseberry)—in treating Amlapitta, commonly known as hyperacidity.

The research evaluates the pharmacological properties, therapeutic actions, and potential benefits of these remedies in alleviating symptoms such as indigestion, acidity, and gastritis. The study aims to provide scientific evidence supporting their use in managing hyperacidity and offers insights into their mechanisms of action, dosage, and safety profile in the context of Ayurvedic treatment practices.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
16.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Clinically and pathologically diagnosed patient , who are suffering from Amlapitta.

排除标准

  • Subject should not suffering from Amlapitta more than 3 months
  • Age below 16 years and above 50 years
  • Subject reporting with complication like cardiac problem , emphysema, carcinoma etc.
  • will be excluded
  • Pregnant woman and lactating mothers was excluded
  • Subject with gastric malignancy
  • Subject who recently undergo gastro-intestinal surgery.

结局指标

主要结局

Changes in the objective parameters

时间窗: 1 month

次要结局

  • Changes in the clinical sign and symptoms of Amlapitta(1 month)

研究者

发起方
PGIA DSRRAU Jodhpur
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验